Commentary: Impact of Meningococcal Group B OMV Vaccines, Beyond Their Brief
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2017.1381810
Full Text
Open PDFAbstract
Available in full text
Date
November 17, 2017
Authors
Publisher
Informa UK Limited